Anthony D. Piscopio

1.2k total citations
27 papers, 836 citations indexed

About

Anthony D. Piscopio is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Anthony D. Piscopio has authored 27 papers receiving a total of 836 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 17 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Anthony D. Piscopio's work include Synthetic Organic Chemistry Methods (13 papers), Chemical Synthesis and Analysis (11 papers) and Histone Deacetylase Inhibitors Research (7 papers). Anthony D. Piscopio is often cited by papers focused on Synthetic Organic Chemistry Methods (13 papers), Chemical Synthesis and Analysis (11 papers) and Histone Deacetylase Inhibitors Research (7 papers). Anthony D. Piscopio collaborates with scholars based in United States. Anthony D. Piscopio's co-authors include Kevin M. Koch, Nobuto Minowa, Peter Bertinato, Tushar Kanti Chakraborty, K. C. Nicolaou, John F. Miller, Steven D. Burke, Gregory J. Pacofsky, Kazunori Koide and Andreas Termin and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Anthony D. Piscopio

26 papers receiving 785 citations

Peers

Anthony D. Piscopio

PHARM

ONCOL

BIOTE

Klaus Hinterding Germany

Iain A. S. Walters United Kingdom

Takayuki Okuno Japan

Annie Tam United States

Masatoshi Kiuchi Japan

Peter Sheldrake United Kingdom

Andrea M. Zuhl United States

James E. Sheppeck United States

James E. Ray United States

David J. Richard United States

Klaus Hinterding Germany

Anthony D. Piscopio

314 ×0.5

545 ×1.4

65 ×0.6

PHARM

47 ×0.6

ONCOL

50 ×0.9

BIOTE

Citations per year, relative to Anthony D. Piscopio Anthony D. Piscopio (= 1×) peers Klaus Hinterding

Countries citing papers authored by Anthony D. Piscopio

Since Specialization

Citations

This map shows the geographic impact of Anthony D. Piscopio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony D. Piscopio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony D. Piscopio more than expected).

Fields of papers citing papers by Anthony D. Piscopio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony D. Piscopio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony D. Piscopio. The network helps show where Anthony D. Piscopio may publish in the future.

Co-authorship network of co-authors of Anthony D. Piscopio

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony D. Piscopio. A scholar is included among the top collaborators of Anthony D. Piscopio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony D. Piscopio. Anthony D. Piscopio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Soleimani, Milad, Anna Capasso, Uma Giri, et al.. (2023). Elucidating the direct effects of the novel HDAC inhibitor bocodepsin (OKI-179) on T cells to rationally design regimens for combining with immunotherapy. Frontiers in Immunology. 14. 1260545–1260545. 3 indexed citations

Corr, Bradley R., S. Lindsey Davis, Christopher H. Lieu, et al.. (2023). First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors. Cancers. 16(1). 91–91. 7 indexed citations

Diamond, Jennifer R., Todd M. Pitts, Dana Ungermannova, et al.. (2021). Preclinical Development of the Class-I–Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors. Molecular Cancer Therapeutics. 21(3). 397–406. 10 indexed citations

Corr, Bradley R., Jose M. Pacheco, S. Lindsey Davis, et al.. (2021). Phase 1 study of OKI-179, an oral class 1-selective depsipeptide HDAC inhibitor, in patients with advanced solid tumors: Final results.. Journal of Clinical Oncology. 39(15_suppl). 3075–3075. 4 indexed citations

Diamond, John B., Gary Gordon, Bradley R. Corr, et al.. (2020). Initial results from a phase 1 trial of OKI-179, an oral Class 1-selective depsipeptide HDAC inhibitor, in patients with advanced solid tumors. European Journal of Cancer. 138. S12–S12. 1 indexed citations

Diamond, Jennifer R., Xuedong Liu, Gilad S. Gordon, et al.. (2019). Abstract B007: OKI-179 is a novel, oral, class I specific histone deacetylase inhibitor in phase 1 clinical trials. Molecular Cancer Therapeutics. 18(12_Supplement). B007–B007. 2 indexed citations

Nichols, Paul J., et al.. (2006). Preparation of Pyrrolidine‐Based PDE4 Inhibitors via Enantioselective Conjugate Addition of α‐Substituted Malonates to Aromatic Nitroalkenes.. ChemInform. 37(33). 1 indexed citations

Piscopio, Anthony D. & John Robinson. (2004). Recent applications of olefin metathesis to combinatorial chemistry. Current Opinion in Chemical Biology. 8(3). 245–254. 16 indexed citations

Zablocki, Jeff, Rao Kalla, Thao Perry, et al.. (2004). The discovery of a selective, high affinity A2B adenosine receptor antagonist for the potential treatment of asthma. Bioorganic & Medicinal Chemistry Letters. 15(3). 609–612. 56 indexed citations

10.

Reiter, Lawrence A., Kevin M. Koch, Anthony D. Piscopio, et al.. (1998). trans-3-Benzyl-4-hydroxy-7-chromanylbenzoic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor. Bioorganic & Medicinal Chemistry Letters. 8(14). 1781–1786. 11 indexed citations

11.

Miller, John F., Andreas Termin, Kevin M. Koch, & Anthony D. Piscopio. (1998). Stereoselective Synthesis of Functionalized Carbocycles and Heterocycles via an Ester Enolate Claisen/Ring-Closing Metathesis Manifold^,. The Journal of Organic Chemistry. 63(10). 3158–3159. 39 indexed citations

12.

Piscopio, Anthony D., John F. Miller, & Kevin M. Koch. (1998). A second generation solid phase approach to Freidinger lactams: Application of Fukuyama's amine synthesis and cyclative release via ring closing metathesis. Tetrahedron Letters. 39(18). 2667–2670. 37 indexed citations

13.

Showell, Henry J., Maryrose J. Conklyn, Gary P. Hingorani, et al.. (1998). The Preclinical Pharmacological Profile of the Potent and Selective Leukotriene B4 Antagonist CP-195543. Journal of Pharmacology and Experimental Therapeutics. 285(3). 946–954. 37 indexed citations

14.

Piscopio, Anthony D., John F. Miller, & Kevin M. Koch. (1997). Solid phase heterocyclic synthesis via ring closing metathesis: Traceless linking and cyclative cleavage through a carbon-carbon double bond. Tetrahedron Letters. 38(41). 7143–7146. 44 indexed citations

15.

Burke, Steven D., Anthony D. Piscopio, Michael E. Kort, et al.. (1994). Total synthesis of ionophore antibiotic X-14547 A (indanomycin). The Journal of Organic Chemistry. 59(2). 332–347. 33 indexed citations

16.

Piscopio, Anthony D., Nobuto Minowa, Tushar Kanti Chakraborty, et al.. (1993). A highly convergent strategy towards rapamycin. Stereoselective construction of the C⁸–C¹⁸fragment. Journal of the Chemical Society Chemical Communications. 617–618. 20 indexed citations

17.

Nicolaou, K. C., Tushar Kanti Chakraborty, Anthony D. Piscopio, Nobuto Minowa, & Peter Bertinato. (1993). Total synthesis of rapamycin. Journal of the American Chemical Society. 115(10). 4419–4420. 176 indexed citations

18.

Burke, Steven D., Anthony D. Piscopio, & Michael E. Kort. (1991). Stereoselective synthesis of E-β,β-disubstituted alkenylsilanes from α-(mesyloxy)allylsilanes.. Tetrahedron Letters. 32(7). 855–856.

19.

Burke, Steven D., et al.. (1991). Diastereoselectivity enhancement in vinylcuprate addition to β-alkoxyaldehydes via a vinylsilane.. Tetrahedron Letters. 32(7). 857–858. 11 indexed citations

20.

Burke, Steven D., Gregory J. Pacofsky, & Anthony D. Piscopio. (1986). Total synthesis of (±)-isoavenaciolide and (±)-avenaciolide. Tetrahedron Letters. 27(29). 3345–3348. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact